AAAAAA

   
Results: 1-10 |
Results: 10
Three-year results of the Finnish prostate cancer screening trial
Authors: Maattanen, L Auvinen, A Stenman, UH Tammela, T Rannikko, S Aro, J Juusela, H Hakama, M
Citation: L. Maattanen et al., Three-year results of the Finnish prostate cancer screening trial, J NAT CANC, 93(7), 2001, pp. 552-553
Health-related quality of life and cost-effectiveness studies in the European randomised study of screening for prostate cancer and the US Prostate, Lung, Colon and Ovary trial
Authors: Miller, AB Madalinska, JB Church, T Crawford, D Essink-Bot, ML Goel, V de Koning, HJ Maattanen, L Pentikainen, T
Citation: Ab. Miller et al., Health-related quality of life and cost-effectiveness studies in the European randomised study of screening for prostate cancer and the US Prostate, Lung, Colon and Ovary trial, EUR J CANC, 37(17), 2001, pp. 2154-2160
Randomized screening trial for prostate cancer in Finland
Authors: Hakama, M Aro, J Auvinen, A Juusela, H Maattanen, L Stenman, UH Tammela, TLJ
Citation: M. Hakama et al., Randomized screening trial for prostate cancer in Finland, EUR UROL, 39, 2001, pp. 32-32
Prostate cancer screening within a prostate specific antigen range of 3 to3.9 ng./ml.: A comparison of digital rectal examination and free prostate specific antigen as supplemental screening tests
Authors: Makinen, T Tammela, TLJ Hakama, M Stenman, UH Rannikko, S Aro, J Juusela, H Maattanen, L Auvinen, A
Citation: T. Makinen et al., Prostate cancer screening within a prostate specific antigen range of 3 to3.9 ng./ml.: A comparison of digital rectal examination and free prostate specific antigen as supplemental screening tests, J UROL, 166(4), 2001, pp. 1339-1342
Predictors of biological aggressiveness of prostate specific antigen screening detected prostate cancer
Authors: Isola, J Auvinen, A Poutiainen, M Kakkola, L Jarvinen, TAH Maattanen, L Stenman, UH Tammela, T Hakama, M Visakorpi, T
Citation: J. Isola et al., Predictors of biological aggressiveness of prostate specific antigen screening detected prostate cancer, J UROL, 165(5), 2001, pp. 1569-1573
Predicting the outcome of prostate biopsy in screen-positive men by a multilayer perceptron network
Authors: Finne, P Finne, R Auvinen, A Juusela, H Aro, J Maattanen, L Hakama, M Rannikko, S Tammela, TLJ Stenman, UH
Citation: P. Finne et al., Predicting the outcome of prostate biopsy in screen-positive men by a multilayer perceptron network, UROLOGY, 56(3), 2000, pp. 418-422
Use of the complex between prostate specific antigen and alpha 1-protease inhibitor for screening prostate cancer
Authors: Finne, P Zhang, WM Auvinen, A Leinonen, J Maattanen, L Rannikko, S Tammela, TLJ Stenman, UH
Citation: P. Finne et al., Use of the complex between prostate specific antigen and alpha 1-protease inhibitor for screening prostate cancer, J UROL, 164(6), 2000, pp. 1956-1960
Insulin-like growth factor I is not a useful marker of prostate cancer in men with elevated levels of prostate-specific antigen
Authors: Finne, P Auvinen, A Koistinen, H Zhang, WM Maattanen, L Rannikko, S Tammela, T Seppala, M Hakama, M Stenman, UH
Citation: P. Finne et al., Insulin-like growth factor I is not a useful marker of prostate cancer in men with elevated levels of prostate-specific antigen, J CLIN END, 85(8), 2000, pp. 2744-2747
Rationale for randomised trials of prostate cancer screening
Authors: Alexander, FE Andriole, GL Aus, G Auvinen, A Beensterboer, P Blijenberg, BG Bonardi, R Buys, S Candas, B Ciatto, S Crawford, ED Demers, R de Koning, HJ Denis, L Dijk, MA Figueiredo, F Gellman, EP Gohagan, J Hakama, M Hugosson, J Kirkels, WI Kranse, R van der Kwast, TH Lilja, H Maattanen, L Mandel, J Miller, AB Monteiro, H Nelen, V Oberman, A Paez, A Prorok, PC Reding, D Rietbergen, JWBW Rose, DB Sanchez, AB Schroder, FH da Silva, EC Simpson, N Smith, PH Stadaert, B Stenman, UH Teppo, L Turkes, A Weissfeld, JL Yokochi, L
Citation: Fe. Alexander et al., Rationale for randomised trials of prostate cancer screening, EUR J CANC, 35(2), 1999, pp. 262-271
European randomized study of prostate cancer screening: first-year resultsof the Finnish trial
Authors: Maattanen, L Auvinen, A Stenman, UH Rannikko, S Tammela, T Aro, J Juusela, H Hakama, M
Citation: L. Maattanen et al., European randomized study of prostate cancer screening: first-year resultsof the Finnish trial, BR J CANC, 79(7-8), 1999, pp. 1210-1214
Risultati: 1-10 |